Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03379740 · ClinicalTrials.gov registry record · NA
Study to Investigate the Nicotine Pharmacokinetic Profiles and Pharmacodynamic Effects of P4M3 Variants
A NA study, sponsored by Philip Morris Products S.A..
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT03379740 is a NA study that has completed, run by Philip Morris Products S.A.. The registered enrollment target is 15 participants.
The verdict
NCT03379740, a NA study, has completed, sponsored by Philip Morris Products S.A..
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
This is a single-center, open-label, concentration-ranging study to evaluate the nicotine PK profile and PD effects in healthy adult experienced users of closed tank/cartridge e-cigarettes using four different variants of P4M3 (nicotine concentration of 1.7%, 1.7% with 1.1% lactic acid \[LA\], 3% with 1.1% LA, and 4% with 2% LA) or their own e-cigarettes.
Interventions
- OTHER E-cigarette
- OTHER P4M3-1.7%
- OTHER P4M3-1.7%LA
- OTHER P4M3-3%LA
- OTHER P4M3-4%LA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2017-07-11 |
| Est. Completion | 2017-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03379740
The ClinicalTrials.gov registry entry for NCT03379740 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philip Morris Products S.A., which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which E-cigarette is the first listed.
NCT03379740 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03379740 about?
NCT03379740 is a clinical study titled "Study to Investigate the Nicotine Pharmacokinetic Profiles and Pharmacodynamic Effects of P4M3 Variants". This is a single-center, open-label, concentration-ranging study to evaluate the nicotine PK profile and PD effects in healthy adult experienced users of closed tank/cartridge e-cigarettes using four different variants of P4M3 (nicotine concentration of 1.7%, 1.7% with 1.1% lactic acid \[LA\], 3% wi...
What is the current status of trial NCT03379740?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2017-07-11. Estimated completion is 2017-12-01.
What interventions are being tested in trial NCT03379740?
The interventions under investigation include: E-cigarette (OTHER), P4M3-1.7% (OTHER), P4M3-1.7%LA (OTHER), P4M3-3%LA (OTHER), P4M3-4%LA (OTHER).
Who is sponsoring clinical trial NCT03379740?
This trial is sponsored by Philip Morris Products S.A., which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.